NCT07354048

Brief Summary

This study aims to evaluate the effect of thyroid dysfunction on liver function tests.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 14, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 30, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 21, 2026

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

7 months

First QC Date

September 30, 2025

Last Update Submit

January 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measuring total bilirubin level in patients with thyroid dysfunction diseases

    Collecting blood samples from the patients

    1 months

Study Arms (4)

Control group

Other: Control group

Patients with hypothyroidism or hyperthyroidism that are controlled on treatment

Other: Patients with hypothyroidism or hyperthyroidism that are controlled on treatment

Patients with hypothyroidism or hyperthyroidism that are not controlled on treatment

Other: Patients with hypothyroidism or hyperthyroidism that are not controlled on treatment

Patients with hypothyroidism or hyperthyroidism that are firstly discovered

Other: Patients with hypothyroidism or hyperthyroidism that are firstly discovered

Interventions

This group includes patients with hypothyroidism or hyperthyroidism that are not controlled on treatment

Patients with hypothyroidism or hyperthyroidism that are not controlled on treatment

This group includes patients with hypothyroidism or hyperthyroidism that are firstly discovered

Patients with hypothyroidism or hyperthyroidism that are firstly discovered

Healthy people

Control group

This group includes patients with hypothyroidism or hyperthyroidism that are controlled on treatment

Patients with hypothyroidism or hyperthyroidism that are controlled on treatment

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

All patients between the ages of 20-60 years old either with Hypothyroidism or Hyperthyroidism (controlled on treatment or not) and firstly diagnosed Hypothyroidism or Hyperthyroidism.

You may qualify if:

  • All patients between the ages of 20-60 years old either with Hypothyroidism or Hyperthyroidism (controlled on treatment or not) and firstly diagnosed Hypothyroidism or Hyperthyroidism.
  • Euthyroid controls (clinically healthy control subjects were recruited from the general population with the same socio-economic status with the subjects.)

You may not qualify if:

  • Patients aged \< 20 years old.
  • Patients With Liver Disease.
  • Pregnant and lactating women.
  • Patients with severe infections or sepsis.
  • Patients with Heart Disease.
  • Patients who on drugs that can affect liver function such as phenothiazine, phenylbutazone, methyldopa, among others.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University Hospital

Sohag, Egypt

RECRUITING

Related Publications (3)

  • Boelaert K, Franklyn JA. Thyroid hormone in health and disease. J Endocrinol. 2005 Oct;187(1):1-15. doi: 10.1677/joe.1.06131.

    PMID: 16214936BACKGROUND
  • Malik R, Hodgson H. The relationship between the thyroid gland and the liver. QJM. 2002 Sep;95(9):559-69. doi: 10.1093/qjmed/95.9.559.

    PMID: 12205333BACKGROUND
  • Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002 Feb;23(1):38-89. doi: 10.1210/edrv.23.1.0455.

    PMID: 11844744BACKGROUND

MeSH Terms

Conditions

Thyroid Diseases

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Endocrine System Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Central Study Contacts

Omnia A Mohamed, Resident

CONTACT

Usama M Abdel-Aal, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident, Internal Medicine Department, Faculty of Medicine, Sohag University

Study Record Dates

First Submitted

September 30, 2025

First Posted

January 21, 2026

Study Start

July 14, 2025

Primary Completion

January 30, 2026

Study Completion

January 30, 2026

Last Updated

January 21, 2026

Record last verified: 2026-01

Locations